Erica Rogers joins Medicines360's Board of Directors

A global mission-driven women's health company, Medicines360 has appointed Erica Rogers to the Board of Directors on March 8, 2024. Headquartered in San Francisco, the firm caters in Pharmaceutical Manufacturing Industry, having founded in 2009. Medicines360 is a non-profit pharmaceutical organization that focuses on augmenting new products in addition to accelerating access to innovation for women.

Erica Rogers carry 3 decades of experience in Medtech sector while having worked with different firms that includes HistoSonics, Sight Sciences, Venture Investors, Silk Road Medical and so forth. Prior her appointment in Board of Directors, she was the Chief Operating Officer (COO) of Medicines360 for 2 years i.e., from 2010 to 2012.

She exclaims, “Medicines360 has demonstrated considerable impact, helping over 1.5 million women to date, driven by its mission to improve equitable health outcomes. I’m honored to return to the organization at this pivotal growth stage and accelerate the timeline from health innovation to access for all women.”

Andrea Olariu, CEO at Medicines360 said in a statement, “We are thrilled to welcome Erica Rogers to our Board of Directors. Ms. Rogers’ extensive experience and leadership in navigating the complex drug and device commercialization landscape will be invaluable to our organization. She will be a key advisor to us as we expand our product portfolio offerings to address additional unmet needs in the area of women’s health.”